Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
C4A antisense RNA 1 (C4A-AS1) is an annotated antisense long non-coding RNA (lncRNA) mapped to the human C4A gene locus (complement component 4A), with record in the NCBI Gene database (Gene ID: 106478955)[5]. As with other antisense RNAs, it is transcribed from the strand opposite to its associated coding gene (C4A), but to date, there are no functional studies or reports describing its role, biological activity, disease associations, or relevance as a therapeutic target. It does not appear in the scientific literature as a characterized or actionable molecule. Therefore, its significance and function remain unknown. If you intended a different or more established antisense RNA (for example, those associated with diseases or studied in functional biology or oncology), please clarify or provide an alternate name, as "C4A antisense RNA 1" currently lacks sufficient scientific characterization[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on C4A antisense RNA 1 (C4A-AS1).